Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/INM/Net margin

INMED PHARMACEUTICALS INC. (INM) Net margin 2021–2025

INMED PHARMACEUTICALS INC. (INM) net profit margin by fiscal year — reported net income divided by reported revenue.

-165.1%FY2025 · since FY2021: -535.9% → -165.1%
2122232425
Fiscal yearValueYoY
FY2025-165.1%+1.8 pp
FY2024-166.9%+25.2 pp
FY2023-192.2%+1169.7 pp
FY2022-1361.9%-826.0 pp
FY2021-535.9%—

Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.

Source: SEC XBRL filings · For reference only · Not investment advice

More INM financial trends

INM RevenueINM Net incomeINM Gross profitINM Gross marginINM Operating incomeINM Operating marginINM Operating cash flowINM Free cash flowINM Capital expendituresINM Return on equityINM Stock buybacksINM Dividends paidINM Total assetsINM Total liabilitiesINM Shareholders’ equityINM overview →